≡

ELISA Kit for Uroplakin 3A (UPK3A)

UPIII; UPK3

Specificity

This assay has high sensitivity and excellent specificity for detection of Uroplakin 3A (UPK3A).
No significant cross-reactivity or interference between Uroplakin 3A (UPK3A) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Uroplakin 3A (UPK3A) and the recovery rates were calculated by comparing the measured value to the expected amount of Uroplakin 3A (UPK3A) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-101 92
EDTA plasma(n=5) 85-93 88
heparin plasma(n=5) 92-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Uroplakin 3A (UPK3A) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Uroplakin 3A (UPK3A) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Uroplakin 3A (UPK3A) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-99% 79-93% 91-103% 89-99%
EDTA plasma(n=5) 80-105% 96-104% 95-102% 78-101%
heparin plasma(n=5) 92-103% 95-102% 93-104% 88-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Biomed Research International Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis Pubmed:30069482
International Journal of Urology Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti‐inflammatory effects Pubmed:29268303
. Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases 34944460
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPF558Ra01 Recombinant Uroplakin 3A (UPK3A) Positive Control; Immunogen; SDS-PAGE; WB.
PAF558Ra01 Polyclonal Antibody to Uroplakin 3A (UPK3A) WB; IHC; ICC; IP.
MAF558Ra21 Monoclonal Antibody to Uroplakin 3A (UPK3A) WB; IHC; ICC; IP.
SEF558Ra ELISA Kit for Uroplakin 3A (UPK3A) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF558Ra Multiplex Assay Kit for Uroplakin 3A (UPK3A) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.